9 research outputs found

    Association of bacterial genotypes and epidemiological features with treatment failure in hemodialysis patients with methicillin-resistant <i>Staphylococcus aureus</i> bacteremia

    No full text
    <div><p>Objectives</p><p>Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infections in the hemodialysis (HD) population are epidemiologically classified as healthcare-associated infections. The data about the clinical impact and bacterial characteristics of hospital-onset (HO)- and community-onset (CO)-MRSA in HD patients are scarce. The current study analyzed the difference in the clinical and molecular characteristics of HO-MRSA and CO-MRSA.</p><p>Methods</p><p>We performed a retrospective review and molecular analysis of clinical isolates from 106 HD patients with MRSA bacteremia from 2009 to 2014. CA genotypes were defined as isolates carrying the SCC<i>mec</i> type IV or V, and HA genotypes were defined as isolates harboring SCC<i>mec</i> type I, II, or III.</p><p>Results</p><p>CO-MRSA infections occurred in 76 patients, and 30 patients had HO-MRSA infections. There was no significant difference in the treatment failure rates between patients with CO-MRSA infections and those with HO-MRSA infections. CA genotypes were associated with less treatment failure (odds ratio [OR]: 0.18; 95% confidence interval [95% CI], 0.07–0.49; <i>p</i> = 0.001). For isolates with a vancomycin minimum inhibitory concentration (MIC) < 1.5 mg/L, the multivariate analysis revealed that HA genotypes and cuffed tunneled catheter use were associated with treatment failure. For isolates with a vancomycin MIC ≥1.5 mg/L, the only risk factor for treatment failure was a higher Pitt score (OR: 1.76; 95% CI, 1.02–3.05; <i>p</i> = 0.043).</p><p>Conclusion</p><p>CA genotypes, but not the epidemiological classification of CO-MRSA, impacted the clinical outcome of MRSA bacteremia in the HD population.</p></div

    Demographic data, clinical features, molecular characteristics and therapeutic characteristics between healthcare-associated community onset (CO)- and healthcare-associated hospital onset (HO)- methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infections in hemodialysis patients.

    No full text
    <p>Demographic data, clinical features, molecular characteristics and therapeutic characteristics between healthcare-associated community onset (CO)- and healthcare-associated hospital onset (HO)- methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infections in hemodialysis patients.</p

    Multivariate analyses of the association between potential predictor variables and treatment failure in patients with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia.

    No full text
    <p>Multivariate analyses of the association between potential predictor variables and treatment failure in patients with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia.</p

    Univariate analyses of the association between potential predictor variables and treatment failure in patients with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia.

    No full text
    <p>Univariate analyses of the association between potential predictor variables and treatment failure in patients with methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) bacteremia.</p
    corecore